En esta página
01IMVT precio
02Instantánea
03Gráfico
06Rendimiento
07Valoración y ratios
14Ganancias
15Fundamentales Completos
16Estados Financieros
17Propietarios institucionales (13F)
18Activistas y propietarios del %+ 5
19Informantes de la empresa
20Propiedad de ETFs
21Consenso
22Pares
23Noticias
26Mis Métricas
IMVT Immunovant, Inc. - Common Stock
NASDAQ · Biotechnology · Ver en SEC EDGAR ↗ cerrar Oct 2, 2026 10-K/10-Q Ago 6, 2026
$33,62
· % del rango de 52 semanas
· por encima del mínimo
· a alto
$15,95mínimo 52 semanas
$45,42máximo 52 semanas
Capitalización Bursátil (MRQ)
$6.93B
P/E
-12.1
BPA
$-2.77
tus insignias
Rango 52S
$16–$45
Calificación del Analista
STRONG BUY
Precio Objetivo
$49
P/E
-12.1
ROE
-73.7%
Margen de Beneficio Neto
·
Tu barra de insignias está vacía — fija una métrica en cualquier lugar de esta página.
IMVT Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas
Precio
$33.62
Capitalización Bursátil (MRQ)
$6.93B
P/E
-12.1
BPA
$-2.77
ROE
-73.7%
Rango 52S
$16–$45
IMVT Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista
rango
barras
La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.
Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA
BPA$-2.772021-03-31 → 2026-03-31
Flujo de caja libre$-407M2020-03-31 → 2026-03-31
Margen neto·2023-03-31 → 2024-03-31
Valoración y ratios
Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?
| Métrica | Tendencia a 5 años | IMVT | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| P/E | -12.1promedio 5A ≈-9.1 | ≈-9.1 | · | · | |
| P/S | 351.4promedio 5A ≈216.0 | ≈216.0 | 102.4 | Sobrevalorado | |
| P/C (MRQ) | 9.4promedio 5A ≈4.9 | ≈4.9 | 9.0 | Más caro | |
| Price / FCF (Precio / FCF) | -16.8promedio 5A ≈-11.8 | ≈-11.8 | · | · | |
| Price / Cash Flow (Precio / Flujo de Caja) | -16.8promedio 5A ≈-11.8 | ≈-11.8 | · | · | |
| Price / Tangible Book (Precio / Valor Contable Tangible) | 8.0promedio 5A ≈4.9 | ≈4.9 | · | · |
La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.
Rentabilidad Márgenes brutos, operativos y netos; ROE, ROA, ROIC
| Métrica | Tendencia a 5 años | IMVT | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| ROA | -58.3%promedio 5A ≈-48.7% | ≈-48.7% | -22.4% | Débil | |
| ROE | -73.7%promedio 5A ≈-55.6% | ≈-55.6% | -47.3% | Débil |
Salud financiera Deuda, liquidez, solvencia — solidez del balance general
| Métrica | Tendencia a 5 años | IMVT | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Ratio corriente (MRQ) | 7.3promedio 5A ≈11.0 | ≈11.0 | 7.9 | Baja liquidez | |
| Quick Ratio (Ratio Rápido) | 8.6promedio 5A ≈10.5 | ≈10.5 | 6.5 | Liquidez sólida |
Crecimiento Crecimiento de ingresos, BPA y beneficio neto: interanual, CAGR a 3 años, CAGR a 5 años
| Métrica | Tendencia a 5 años | IMVT | promedio 5A | Mediana de Pares | Veredicto |
|---|---|---|---|---|---|
| Revenue YoY (Ingresos interanuales) | 229.2% | · | · | · |
Eficiencia de capital Rotación de activos, rotación de inventario, rotación de cuentas por cobrar
Aún no hay datos para este grupo de ratios
Aún no hay datos fundamentales para este ticker.
valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana
Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados
Tasa de Superación
25.0%
Sorpresa Media
-7.0%
Próximo informe
Nov 09, 2026
| Período | Informe | EPS Actual | EPS est. | Sorpresa |
|---|---|---|---|---|
| 31 de marzo de 2027 | Ago 12, 2026 | $-0.75 | $-0.63 | -19.5% |
| 31 de diciembre de 2026 | May 20, 2026 | $-0.73 | $-0.61 | -19.1% |
| 30 de junio de 2026 | $-0.75 | $-0.63 | -19.5% | |
| 31 de marzo de 2026 | $-0.73 | $-0.61 | -19.1% | |
| 31 de diciembre de 2025 | $-0.61 | $-0.73 | 16.3% | |
| 30 de septiembre de 2025 | $-0.73 | $-0.73 | 0.21% | |
| 30 de junio de 2025 | $-0.71 | $-0.66 | -8.0% | |
| 31 de marzo de 2025 | $-0.64 | $-0.73 | 12.4% |
Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja
Estado de resultados
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | · | · | · | · | $102M | $69M | $48M | $26M | |
| SG&A Expense | $76M | $77M | $57M | $48M | $54M | $40M | $18M | $3M | |
| Operating Expenses | $533M | $438M | $283M | $218M | $156M | $108M | $66M | $28M | |
| Interest Expense | · | · | · | · | · | $0 | $625.0K | · | |
| Other Non-op | $2M | $471.0K | $-1M | $-253.0K | $-781.0K | $328.0K | $412.0K | $-155.0K | |
| Pretax Income | $-505M | $-413M | $-259M | $-211M | $-157M | $-108M | $-66M | $-29M | |
| Income Tax | $215.0K | $891.0K | $567.0K | $9.0K | $-84.0K | $-358.0K | $97.0K | $19.0K | |
| Net Income | $-506M | $-414M | $-259M | $-211M | $-157M | $-107M | $-66M | $-29M | |
| EPS (Basic) | $-2.77 | $-2.73 | $-1.88 | $-1.71 | $-1.43 | $-1.22 | · | · | |
| EPS (Diluted) | $-2.77 | $-2.73 | $-1.88 | $-1.71 | $-1.43 | $-1.22 | · | · | |
| Shares (Basic) | 182,421,233 | 151,573,553 | 138,100,577 | 123,075,329 | 109,679,256 | 87,756,513 | · | · | |
| Shares (Diluted) | 182,421,233 | 151,573,553 | 138,100,577 | 123,075,329 | 109,679,256 | 87,756,513 | · | · |
Balance general
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $902M | $714M | $635M | $377M | $494M | $400M | $101M | $7M | |
| Receivables | $1M | $2M | $5M | $700.0K | $12M | $596.0K | · | · | |
| Prepaid Expense | $46M | $51M | $25M | $27M | $6M | $8M | $5M | $3M | |
| Current Assets | $949M | $768M | $666M | $404M | $513M | $409M | $109M | $13M | |
| PP&E (Net) | $443.0K | $844.0K | $462.0K | $333.0K | $330.0K | $201.0K | $65.0K | $54.0K | |
| Other Non-current Assets | $8M | $8M | $0 | · | · | · | · | · | |
| Total Assets | $957M | $776M | $666M | $406M | $516M | $412M | $109M | $14M | |
| Accounts Payable | $8M | $18M | $7M | $1M | $19M | $2M | $1M | $206.0K | |
| Accrued Liabilities | $97M | $51M | $41M | $40M | $25M | $15M | $11M | $6M | |
| Current Liabilities | $104M | $69M | $49M | $43M | $45M | $19M | $15M | · | |
| Capital Leases | · | · | $0 | $47.0K | $1M | $2M | $0 | · | |
| Total Liabilities | $104M | $69M | $49M | $43M | $46M | $21M | $15M | $6M | |
| Common Stock | $20.0K | $16.0K | $14.0K | $13.0K | $12.0K | $10.0K | $5.0K | $4.0K | |
| Paid-in Capital | $2.60B | $1.95B | $1.44B | $928M | $825M | $590M | $185M | $32M | |
| Retained Earnings | $-1.75B | $-1.24B | $-826M | $-566M | $-355M | $-199M | $-91M | $-25M | |
| AOCI | $730.0K | $1M | $2M | $852.0K | $404.0K | $-298.0K | $-16.0K | $346.0K | |
| Stockholders' Equity | $853M | $707M | $618M | $362M | $470M | $391M | $94M | $7M | |
| Liabilities + Equity | $957M | $776M | $666M | $406M | $516M | $412M | $109M | $14M | |
| Shares Outstanding | 203,940,353 | 170,111,593 | 145,582,999 | 130,329,863 | 116,482,899 | 97,971,243 | 54,655,376 | 38,590,381 |
Flujo de Efectivo
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $56M | $49M | $41M | $32M | $34M | $19M | $7M | $1M | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Operating Cash Flow | $-407M | $-376M | $-214M | $-188M | $-106M | $-83M | $-53M | $-29M | |
| CapEx | $8.0K | $759.0K | $360.0K | $197.0K | $254.0K | $210.0K | $31.0K | $52.0K | |
| Investing Cash Flow | $-8.0K | $-759.0K | $-360.0K | $-197.0K | $-254.0K | $-210.0K | $-31.0K | $-52.0K | |
| Stock Issued | $544M | $450M | $473M | · | · | · | · | $15M | |
| Net Stock Activity | $544M | · | · | · | · | · | · | · | |
| Financing Cash Flow | $596M | $454M | $472M | $71M | $200M | $383M | $147M | $36M | |
| Net Change in Cash | $188M | $79M | $259M | $-117M | $94M | $300M | $94M | $7M | |
| Taxes Paid | $2M | · | $509.0K | $0 | · | · | · | · | |
| Free Cash Flow | $-407M | $-377M | $-215M | $-188M | $-106M | $-84M | $-53M | · | |
| Levered FCF | · | · | · | · | · | $-84M | $-54M | · |
Rentabilidad
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Net Margin | · | · | -1039.5% | -2783.8% | · | · | · | · | |
| Pretax Margin | · | · | -1037.2% | -2783.7% | · | · | · | · | |
| ROA | -58.3% | -57.4% | -48.4% | -45.8% | -33.8% | -41.2% | -107.8% | · | |
| ROE | -73.7% | -78.1% | -40.0% | -54.3% | -32.1% | -26.7% | -64.5% | · |
Liquidez y Solvencia
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.1 | 11.2 | 13.7 | 9.3 | 11.5 | 21.8 | · | · | |
| Quick Ratio | 8.6 | 10.4 | 13.2 | 8.7 | 11.4 | 21.3 | · | · |
Eficiencia
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | · | · | · | · | |
| Receivables Turnover | · | · | 8.3 | 1.2 | · | · | · | · |
Por Acción
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $4.18 | $4.16 | $4.24 | $2.78 | $4.03 | $4.00 | $1.72 | · | |
| Revenue / Share | · | · | $0.18 | $0.06 | · | · | · | · | |
| Cash Flow / Share | $-2.23 | $-2.48 | $-1.55 | $-1.53 | $-0.97 | · | · | · | |
| Cash / Share | $4.42 | $4.20 | $4.36 | $2.89 | $4.24 | $4.08 | $1.84 | · | |
| EPS (TTM) | $-2.77 | $-2.73 | $-1.88 | $-1.71 | $-1.43 | $-1.22 | · | · |
Tasas de Crecimiento
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | 229.2% | · | · | · | · | · |
Valoración (TTM)
| Métrica | Tendencia | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $20M | $20M | $25M | $8M | $0 | · | · | · | |
| Net Income TTM | $-506M | $-414M | $-259M | $-211M | $-157M | $-107M | $-66M | · | |
| Market Cap | $5.07B | $2.91B | $4.70B | $2.02B | $642M | $1.57B | $851M | · | |
| P/E | -9.0 | -6.3 | -17.2 | -9.1 | -3.9 | -13.1 | · | · | |
| P/S | 259.6 | 149.0 | 188.5 | 266.7 | · | · | · | · | |
| P/B | 5.9 | 4.1 | 7.6 | 5.6 | 1.4 | 4.0 | 9.0 | · | |
| P / Tangible Book | 5.9 | 4.1 | 7.6 | 5.6 | 1.4 | 4.0 | · | · | |
| P / Cash Flow | -12.4 | -7.7 | -22.0 | -10.7 | -6.0 | -18.9 | -15.9 | · | |
| P / FCF | -12.4 | -7.7 | -21.9 | -10.7 | -6.0 | -18.8 | -15.9 | · | |
| Earnings Yield | -11.2% | -16.0% | -5.8% | -11.0% | -25.9% | -7.6% | · | · |
Estado de resultados
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $38M | $28M | |
| SG&A Expense | $18M | $17M | $15M | $18M | $26M | $20M | $20M | $18M | $19M | $15M | $13M | $14M | $15M | $12M | $12M | $12M | |
| Operating Expenses | $160M | $160M | $114M | $132M | $127M | $114M | $114M | $116M | $94M | $81M | $62M | $62M | $78M | $64M | $50M | $40M | |
| Other Non-op | $4.0K | $798.0K | $-54.0K | $250.0K | $1M | $1M | $-1M | $629.0K | $28.0K | $-3M | $1M | $20.0K | $464.0K | $-2M | $793.0K | $354.0K | |
| Pretax Income | $-153M | $-151M | $-109M | $-126M | $-120M | $-106M | $-111M | $-109M | $-87M | $-75M | $-52M | $-58M | $-74M | $-63M | $-48M | $-40M | |
| Income Tax | $0 | $-3M | $2M | $594.0K | $913.0K | $584.0K | $152.0K | $78.0K | $77.0K | $232.0K | $-108.0K | $454.0K | $-11.0K | $387.0K | $261.0K | $352.0K | |
| Net Income | $-153M | $-148M | $-111M | $-127M | $-121M | $-106M | $-111M | $-109M | $-87M | $-75M | $-51M | $-59M | $-74M | $-63M | $-48M | $-40M | |
| EPS (Basic) | $-0.75 | $-0.72 | $-0.61 | $-0.73 | $-0.71 | $-0.63 | $-0.76 | $-0.74 | $-0.60 | $-0.50 | $-0.36 | $-0.45 | $-0.57 | $-0.49 | $-0.41 | $-0.35 | |
| EPS (Diluted) | $-0.75 | $-0.72 | $-0.61 | $-0.73 | $-0.71 | $-0.63 | $-0.76 | $-0.74 | $-0.60 | $-0.50 | $-0.36 | $-0.45 | $-0.57 | $-0.49 | $-0.41 | $-0.35 | |
| Shares (Basic) | 205,545,373 | · | 181,513,386 | 173,643,829 | 170,872,994 | · | 146,922,338 | 146,468,991 | 146,085,729 | · | 144,523,034 | 131,155,642 | 130,503,264 | 128,574,190 | 116,572,820 | 116,557,508 | |
| Shares (Diluted) | 205,545,373 | · | 181,513,386 | 173,643,829 | 170,872,994 | · | 146,922,338 | 146,468,991 | 146,085,729 | · | 144,523,034 | 131,155,642 | 130,503,264 | 128,574,190 | 116,572,820 | 116,557,508 |
Balance general
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $798M | $902M | $995M | $522M | $599M | $714M | $375M | $473M | $560M | $635M | $691M | $270M | $330M | $433M | $406M | $427M | |
| Receivables | $697.0K | $1M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $5M | $1M | $1M | $823.0K | $704.0K | $4M | $13M | |
| Prepaid Expense | $53M | $43M | $47M | $50M | $51M | $51M | $36M | $33M | $27M | $25M | $19M | $20M | $19M | $21M | $17M | $16M | |
| Current Assets | $851M | $949M | $1.04B | $574M | $652M | $768M | $413M | $507M | $589M | $666M | $711M | $291M | $350M | $454M | $426M | $456M | |
| PP&E (Net) | $351.0K | $443.0K | $531.0K | $632.0K | $737.0K | $844.0K | $752.0K | $671.0K | $565.0K | $462.0K | $376.0K | $304.0K | $325.0K | $362.0K | $312.0K | $328.0K | |
| Other Non-current Assets | $961.0K | $8M | $9M | $9M | $9M | $8M | $8M | $8M | · | $0 | · | · | · | · | · | · | |
| Total Assets | $852M | $957M | $1.05B | $583M | $661M | $776M | $421M | $516M | $590M | $666M | $711M | $292M | $351M | $456M | $428M | $459M | |
| Accounts Payable | $10M | $8M | $9M | $7M | $8M | $18M | $20M | $21M | $11M | $7M | $4M | $8M | $26M | $14M | $7M | $1M | |
| Accrued Liabilities | · | $97M | · | · | · | $51M | $48M | $46M | $34M | $41M | $28M | $32M | $24M | $26M | $23M | $19M | |
| Current Liabilities | $117M | $104M | $66M | $63M | $53M | $69M | $68M | $67M | $45M | $49M | $32M | $40M | $51M | $41M | $32M | $21M | |
| Capital Leases | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $306.0K | $614.0K | $919.0K | |
| Total Liabilities | $117M | $104M | $66M | $63M | $53M | $69M | $68M | $67M | $45M | $49M | $32M | $40M | $51M | $42M | $32M | $22M | |
| Common Stock | $20.0K | $20.0K | $20.0K | $17.0K | $16.0K | $16.0K | $14.0K | $14.0K | $14.0K | $14.0K | $14.0K | $13.0K | $13.0K | $13.0K | $12.0K | $12.0K | |
| Paid-in Capital | $2.63B | $2.60B | $2.58B | $2.00B | $1.97B | $1.95B | $1.48B | $1.47B | $1.46B | $1.44B | $1.43B | $950M | $940M | $920M | $841M | $833M | |
| Retained Earnings | $-1.90B | $-1.75B | $-1.60B | $-1.49B | $-1.36B | $-1.24B | $-1.13B | $-1.02B | $-913M | $-826M | $-750M | $-699M | $-640M | $-507M | $-444M | $-396M | |
| AOCI | $725.0K | $730.0K | $1M | $1M | $2M | $1M | $2M | $2M | $2M | $2M | $-600.0K | $513.0K | $582.0K | $1M | $-1M | $-263.0K | |
| Stockholders' Equity | $735M | $853M | $986M | $520M | $609M | $707M | $353M | $449M | $545M | $618M | $679M | $252M | $300M | $415M | $396M | $436M | |
| Liabilities + Equity | $852M | $957M | $1.05B | $583M | $661M | $776M | $421M | $516M | $590M | $666M | $711M | $292M | $351M | $456M | $428M | $459M | |
| Shares Outstanding | 206,264,878 | 203,940,353 | 203,316,885 | 174,532,710 | 171,069,176 | 170,111,593 | 147,203,565 | 146,565,049 | 146,195,673 | 145,582,999 | 145,094,052 | 131,442,024 | 130,565,429 | 129,260,254 | 116,614,088 | 116,524,158 |
Flujo de Efectivo
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $14M | $11M | $13M | $13M | $19M | $12M | $12M | $13M | $13M | $10M | $10M | $11M | $11M | $9M | $8M | $8M | |
| Operating Cash Flow | $-124M | $-95M | $-92M | $-103M | $-117M | $-111M | $-100M | $-89M | $-76M | $-60M | $-47M | $-60M | $-47M | $-46M | $-20M | $-66M | |
| CapEx | · | $8.0K | $0 | $0 | $0 | $201.0K | $180.0K | $196.0K | $182.0K | $150.0K | $131.0K | $34.0K | $45.0K | $98.0K | $31.0K | $42.0K | |
| Investing Cash Flow | · | $-8.0K | $0 | $0 | $0 | $-201.0K | $-180.0K | $-196.0K | $-182.0K | $-150.0K | $-131.0K | $-34.0K | $-45.0K | $-98.0K | $-31.0K | $-42.0K | |
| Stock Issued | · | $0 | · | · | · | $450M | · | · | · | · | · | · | · | $70M | · | · | |
| Financing Cash Flow | $20M | $4M | $565M | $25M | $3M | $451M | $2M | $730.0K | $686.0K | $2M | $470M | $148.0K | $890.0K | $71M | $0 | $21.0K | |
| Net Change in Cash | $-104M | $-92M | $473M | $-77M | $-115M | $339M | $-98M | $-87M | $-75M | $-56M | $421M | $-60M | $-47M | $27M | $-21M | $-67M | |
| Free Cash Flow | · | · | · | · | $-117M | · | · | · | $-76M | · | · | · | $-47M | · | · | $-66M |
Rentabilidad
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | · | · | · | · | · | · | · | · | · | · | -575.6% | -1642.3% | -1818.9% | -2147.7% | -4153.2% | · | |
| Pretax Margin | · | · | · | · | · | · | · | · | · | · | -576.8% | -1629.6% | -1819.1% | -2134.5% | -4130.6% | · | |
| ROA | -20.2% | · | -15.0% | -23.0% | -19.3% | · | -19.6% | -27.0% | -18.5% | · | -8.8% | -16.3% | -18.3% | -12.7% | -9.6% | -9.5% | |
| ROE | -22.8% | · | -16.5% | -26.1% | -20.9% | · | -21.5% | -31.1% | -20.6% | · | -9.4% | -18.1% | -20.1% | -13.8% | -10.3% | -10.1% |
Liquidez y Solvencia
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.3 | · | 15.7 | 9.1 | 12.3 | · | 6.0 | 7.6 | 13.1 | · | 22.1 | 7.2 | 6.8 | 11.0 | 13.4 | 21.5 | |
| Quick Ratio | 6.8 | · | 15.0 | 8.3 | 11.4 | · | 5.5 | 7.1 | 12.5 | · | 21.6 | 6.7 | 6.4 | 10.5 | 12.9 | 20.7 |
Eficiencia
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | · | · | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | |
| Receivables Turnover | · | · | · | · | · | · | · | · | · | · | 10.3 | 1.4 | 0.6 | 8.4 | 0.6 | · |
Por Acción
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.57 | · | $4.85 | $2.98 | $3.56 | · | $2.40 | $3.06 | $3.73 | · | $4.68 | $1.92 | $2.30 | $3.21 | $3.39 | $3.75 | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | · | $0.06 | $0.03 | $0.03 | $0.02 | $0.01 | · | |
| Cash Flow / Share | $-0.61 | · | · | · | $-0.69 | · | · | · | $-0.52 | · | · | · | $-0.36 | · | · | $-0.56 | |
| Cash / Share | $3.87 | · | $4.89 | $2.99 | $3.50 | · | $2.55 | $3.23 | $3.83 | · | $4.76 | $2.05 | $2.53 | $3.35 | $3.48 | $3.67 | |
| EPS (TTM) | $-2.81 | · | $-2.68 | $-2.83 | $-2.84 | · | $-2.60 | $-2.20 | $-1.91 | · | $-1.84 | $-1.97 | $-1.93 | $-1.66 | $-1.53 | $-1.47 |
Valoración (TTM)
| Métrica | Tendencia | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | · | · | · | · | · | $4M | $1M | $0 | |
| Net Income TTM | $-538M | · | $-464M | $-465M | $-447M | · | $-383M | $-323M | $-273M | · | $-243M | $-255M | $-245M | $-199M | $-177M | $-167M | |
| Market Cap | $7.95B | · | $5.17B | $2.81B | $2.74B | · | $3.65B | $4.18B | $3.86B | · | $6.11B | $5.05B | $2.48B | $2.29B | $651M | $454M | |
| P/E | -13.7 | · | -9.5 | -5.7 | -5.6 | · | -9.5 | -13.0 | -13.8 | · | -22.9 | -19.5 | -9.8 | -10.7 | -3.6 | -2.7 | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | · | · | 559.9 | 563.9 | · | |
| P/B | 10.8 | · | 5.2 | 5.4 | 4.5 | · | 10.3 | 9.3 | 7.1 | · | 9.0 | 20.0 | 8.3 | 5.5 | 1.6 | 1.0 | |
| P / Tangible Book | 10.8 | · | 5.2 | 5.4 | 4.5 | · | 10.3 | 9.3 | 7.1 | · | 9.0 | 20.0 | 8.3 | 5.5 | 1.6 | 1.0 | |
| P / Cash Flow | -63.9 | · | · | · | -23.3 | · | · | · | -50.7 | · | · | · | -52.3 | · | · | -6.9 | |
| Earnings Yield | -7.3% | · | -10.5% | -17.6% | -17.8% | · | -10.5% | -7.7% | -7.2% | · | -4.4% | -5.1% | -10.2% | -9.3% | -27.4% | -37.7% |
Período más reciente a la izquierda · valores nulos mostrados como ·
Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años
| Métrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Beneficio neto | $-506M | $-414M | $-259M | $-211M | $-157M |
| EPS Diluido | $-2.77 | $-2.73 | $-1.88 | $-1.71 | $-1.43 |
| Métrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Ratio corriente | 9.1 | 11.2 | 13.7 | 9.3 | 11.5 |
| Ratio Rápido | 8.6 | 10.4 | 13.2 | 8.7 | 11.4 |
| Métrica | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Flujo de caja libre | $-407M | $-377M | $-215M | $-188M | $-106M |
Propietarios institucionales (13F) 246 declarantes · $4.4B total · A fecha de 30 de junio de 2026
Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.
Tenedores
246
Valor en tenencia
$4.4B
Nuevas posiciones
41
Posiciones cerradas
21
Actividad institucional — Q2 2026 vs trimestre anterior
| Nuevas posiciones | Posiciones cerradas | Aumentado | Disminuido | Cambio neto de acciones |
|---|---|---|---|---|
| 41 (-8 vs trimestre anterior) | 21 (-2 vs trimestre anterior) | 75 (-19 vs trimestre anterior) | 81 (+37 vs trimestre anterior) | +645K |
Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.
| Institución | Valor | Acciones | % de 13F rastreadas | Tipo |
|---|---|---|---|---|
| FMR LLC | $623 664 634 | 16 186 469 | 14,33% | Acciones |
| Deep Track Capital, LP | $359 914 548 | 9 341 151 | 8,27% | Acciones |
| BlackRock, Inc. | $276 679 973 | 7 180 897 | 6,36% | Acciones |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $223 666 650 | 5 805 000 | 5,14% | Acciones |
| BAKER BROS. ADVISORS LP | $209 419 027 | 5 435 220 | 4,81% | Acciones |
| VANGUARD GROUP INC | $197 750 162 | 7 779 314 | 4,54% | Acciones |
| STATE STREET CORP | $177 893 203 | 4 617 005 | 4,09% | Acciones |
| MORGAN STANLEY | $174 727 164 | 4 534 833 | 4,01% | Acciones |
| TCG Crossover Management, LLC | $171 766 278 | 4 457 988 | 3,95% | Acciones |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $150 671 912 | 3 910 509 | 3,46% | Acciones |
| VANGUARD CAPITAL MANAGEMENT LLC | $140 198 379 | 3 638 681 | 3,22% | Acciones |
| JENNISON ASSOCIATES LLC | $127 543 468 | 3 310 238 | 2,93% | Acciones |
| RTW INVESTMENTS, LP | $122 442 522 | 3 177 849 | 2,81% | Acciones |
| Two Seas Capital LP | $121 311 898 | 3 148 505 | 2,79% | Acciones |
| ADAR1 Capital Management, LLC | $89 802 487 | 2 330 716 | 2,06% | Acciones |
| GEODE CAPITAL MANAGEMENT, LLC | $86 115 373 | 2 234 602 | 1,98% | Acciones |
| Woodline Partners LP | $76 130 233 | 1 975 869 | 1,75% | Acciones |
| GOLDMAN SACHS GROUP INC | $67 473 081 | 1 751 183 | 1,55% | Acciones |
| ARMISTICE CAPITAL, LLC | $66 888 080 | 1 736 000 | 1,54% | Acciones |
| Alpine Global Management, LLC | $52 978 748 | 1 375 000 | 1,22% | Acciones |
| PERCEPTIVE ADVISORS LLC | $52 299 967 | 1 357 383 | 1,20% | Acciones |
| D. E. Shaw & Co., Inc. | $47 802 399 | 1 240 654 | 1,10% | Acciones |
| ARMISTICE CAPITAL, LLC | $46 236 000 | 1 200 000 | 1,06% | Opción de compra |
| BANK OF AMERICA CORP /DE/ | $45 521 345 | 1 181 452 | 1,05% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $39 397 426 | 1 022 513 | 0,90% | Acciones |
| Aberdeen Group plc | $33 021 366 | 857 030 | 0,76% | Acciones |
| NORTHERN TRUST CORP | $30 592 975 | 794 004 | 0,70% | Acciones |
| RENAISSANCE TECHNOLOGIES LLC | $28 003 604 | 726 800 | 0,64% | Acciones |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $26 223 210 | 680 592 | 0,60% | Acciones |
| Logos Global Management LP | $25 622 450 | 665 000 | 0,59% | Acciones |
| SILVERARC CAPITAL MANAGEMENT, LLC | $23 853 769 | 619 096 | 0,55% | Acciones |
| Nuveen, LLC | $23 196 833 | 602 046 | 0,53% | Acciones |
| VANGUARD FIDUCIARY TRUST CO | $21 740 398 | 564 246 | 0,50% | Acciones |
| Connor, Clark & Lunn Investment Management Ltd. | $18 262 604 | 473 984 | 0,42% | Acciones |
| UBS Group AG | $18 190 861 | 472 122 | 0,42% | Acciones |
| Pictet Asset Management Holding SA | $17 814 692 | 462 359 | 0,41% | Acciones |
| MILLENNIUM MANAGEMENT LLC | $12 663 963 | 328 678 | 0,29% | Acciones |
| BNP PARIBAS FINANCIAL MARKETS | $12 332 336 | 320 071 | 0,28% | Acciones |
| JANE STREET GROUP, LLC | $11 959 712 | 310 400 | 0,27% | Opción de compra |
| Bank of New York Mellon Corp | $11 396 826 | 295 791 | 0,26% | Acciones |
| HighVista Strategies LLC | $10 706 447 | 277 873 | 0,25% | Acciones |
| STEMPOINT CAPITAL LP | $10 654 585 | 276 527 | 0,24% | Acciones |
| Tetragon Partners GP Ltd | $9 861 137 | 255 934 | 0,23% | Acciones |
| Soleus Capital Management, L.P. | $9 709 560 | 252 000 | 0,22% | Acciones |
| SUPERSTRING CAPITAL MANAGEMENT LP | $8 028 419 | 208 368 | 0,18% | Acciones |
| Granahan Investment Management, LLC | $7 951 513 | 206 372 | 0,18% | Acciones |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7 050 990 | 183 000 | 0,16% | Opción de compra |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6 288 096 | 163 200 | 0,14% | Opción de venta |
| CITADEL ADVISORS LLC | $6 169 539 | 160 123 | 0,14% | Acciones |
| ALGERT GLOBAL LLC | $6 158 635 | 159 840 | 0,14% | Acciones |
Activistas y propietarios del %+ 5 2 tenencias
Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.
| Declarante | Presentado | Participación | Estado | Propósito | Presentación |
|---|---|---|---|---|---|
| Roivant Sciences Ltd. ×11 presentaciones | 12 de diciembre de 2025 | 55,90% | Enmienda | · | SEC |
| Roderick Wong, M.D. | 27 de diciembre de 2019 | · | Presentación inicial | M&A / venta | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Informantes de la empresa 27 insiders · 17 directivos · 12 consejeros
| Insider | Rol | Última actividad | Acciones en propiedad | Compras 12m | Ventas 12m | Neto 12m |
|---|---|---|---|---|---|---|
| Eric Venker | Chief Executive Officer | 1 de julio de 2026 M | 254 280 | 0 | 3 | $-461 834 |
| Peter Salzmann | Chief Executive Officer | 16 de abril de 2025 S | 1 178 191 | 0 | 0 | $0 |
| Roderick Wong, M.D. | Chief Executive Officer | 11 de diciembre de 2019 P | 902 498 | 0 | 0 | $0 |
| Tiago Girao | Chief Financial Officer | 23 de julio de 2026 S | 240 798 | 0 | 3 | $-1 410 626 |
| Eva Renee Barnett | Chief Financial Officer | 16 de abril de 2025 S | 396 774 | 0 | 0 | $0 |
| Connealy Pamela Yanchik | Chief Financial Officer | 19 de marzo de 2021 A | 46 200 | 0 | 0 | $0 |
| Melanie Gloria | Chief Operating Officer | 20 de agosto de 2026 S | 219 301 | 0 | 14 | $-1 600 150 |
| Christopher Van Tuyl | Chief Legal Officer | 23 de septiembre de 2026 S | 176 545 | 0 | 10 | $-1 418 316 |
| Jay S Stout | Chief Technology Officer | 23 de julio de 2026 S | 205 341 | 0 | 15 | $-2 271 089 |
| Michael Geffner | Chief Medical Officer | 22 de octubre de 2025 S | 217 958 | 0 | 2 | $-70 117 |
| William L. Macias | Chief Medical Officer | 19 de febrero de 2025 S | 357 353 | 0 | 0 | $0 |
| Mark S. Levine | Chief Legal Officer | 20 de noviembre de 2024 S | 319 228 | 0 | 0 | $0 |
| Julia G. Butchko | Chief Development Officer | 21 de agosto de 2024 S | 440 959 | 0 | 0 | $0 |
| Michael James Elliott | Chief Scientific Officer | 19 de marzo de 2021 A | 97 600 | 0 | 0 | $0 |
| Rita Jain | Chief Medical Officer | 19 de marzo de 2021 A | 129 365 | 0 | 0 | $0 |
| Bradford W Middlekauff | General Counsel | 15 de mayo de 2020 A | · | 0 | 0 | $0 |
| Robert K Zeldin | Chief Medical Officer | 18 de diciembre de 2019 A | · | 0 | 0 | $0 |
| Atul Pande | Consejero | 28 de agosto de 2026 M | 116 731 | 0 | 5 | $-424 650 |
| Andrew J. Fromkin | Consejero | 28 de mayo de 2026 M | 74 382 | 0 | 4 | $-7 955 300 |
| Robert Graham Susman | Consejero | 1 de mayo de 2026 S | 36 394 | 0 | 1 | $-67 979 |
| Douglas J. Hughes | Consejero | 7 de abril de 2026 A | 134 653 | 0 | 2 | $-348 666 |
| Jake Bauer | Consejero | 7 de abril de 2026 A | 38 896 | 0 | 0 | $0 |
| Frank Torti | Consejero | 7 de abril de 2026 A | 1 009 228 | 0 | 0 | $0 |
| Roivant Sciences Ltd. | Consejero | 12 de diciembre de 2025 P | 113 317 007 | 1 | 0 | $349 999 986 |
| George V Migausky | Consejero | 1 de abril de 2025 A | 137 251 | 0 | 0 | $0 |
| Myrtle S Potter | Consejero | 18 de diciembre de 2019 A | · | 0 | 0 | $0 |
| Health Sciences Holdings, LLC | Propietario del 10% | 18 de diciembre de 2019 J | · | 0 | 0 | $0 |
Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto
Propiedad de ETFs Mantenido por 33 ETFs
El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.
| Fondo | Ponderación | Unidades | A fecha de | Fuente |
|---|---|---|---|---|
| GURU · Global X Funds | 1,59% | 25 151 NS | 31 de julio de 2026 | N-PORT |
| BBC · ETFis Series Trust I | 0,77% | 9 245 NS | 31 de julio de 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,68% | 87 318 NS | 31 de julio de 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,46% | 14 619 SH | 1 de octubre de 2026 | Diario |
| ESSC · Strategy Shares | 0,34% | 3 180 NS | 31 de julio de 2026 | N-PORT |
| IBB · iShares Trust | 0,23% | 618 035 SH | 11 de septiembre de 2026 | Diario |
| IWO · iShares Trust | 0,21% | 801 227 SH | 11 de septiembre de 2026 | Diario |
| PWS · Pacer Funds Trust | 0,19% | 1 193 NS | 31 de julio de 2026 | N-PORT |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,19% | 91 474 SH | 19 de agosto de 2026 | Diario |
| BKSE · BNY Mellon ETF Trust | 0,14% | 3 097 NS | 31 de julio de 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,13% | 23 292 NS | 31 de julio de 2026 | N-PORT |
| ISCG · iShares Trust | 0,11% | 27 234 SH | 11 de septiembre de 2026 | Diario |
| IWM · iShares Trust | 0,11% | 2 184 173 SH | 11 de septiembre de 2026 | Diario |
| RSSL · Global X Funds | 0,11% | 40 851 NS | 31 de julio de 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,10% | 490 917 SH | 19 de agosto de 2026 | Diario |
| VBK · VANGUARD INDEX FUNDS | 0,09% | 1 086 290 SH | 19 de agosto de 2026 | Diario |
| VFMO · VANGUARD WELLINGTON FUND | 0,05% | 28 526 SH | 19 de agosto de 2026 | Diario |
| VB · VANGUARD INDEX FUNDS | 0,04% | 1 883 385 SH | 19 de agosto de 2026 | Diario |
| VHT · VANGUARD WORLD FUND | 0,04% | 199 146 SH | 19 de agosto de 2026 | Diario |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 31 197 SH | 1 de octubre de 2026 | Diario |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 31 435 NS | 31 de julio de 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 887 661 SH | 19 de agosto de 2026 | Diario |
| WSML · iShares Trust | 0,02% | 4 355 SH | 11 de septiembre de 2026 | Diario |
| ESGV · VANGUARD WORLD FUND | 0,01% | 18 937 SH | 19 de agosto de 2026 | Diario |
| ITOT · iShares Trust | 0,00% | 116 576 SH | 11 de septiembre de 2026 | Diario |
| IWV · iShares Trust | 0,00% | 24 022 SH | 10 de septiembre de 2026 | Diario |
| TILT · FlexShares Trust | 0,00% | 2 430 NS | 31 de julio de 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2 600 899 SH | 19 de agosto de 2026 | Diario |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 67 319 SH | 19 de agosto de 2026 | Diario |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7 098 SH | 19 de agosto de 2026 | Diario |
| DFAS · Dimensional ETF Trust | 0,00% | 18 NS | 31 de julio de 2026 | N-PORT |
| ISCB · iShares Trust | · | 3 864 SH | 11 de septiembre de 2026 | Diario |
| SMLF · iShares Trust | · | 16 335 SH | 11 de septiembre de 2026 | Diario |
IMVT Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista
calificación · 23 analistas
COMPRA
Objetivo mediano
$48.50
+44,3%
9 39,1%
Compra fuerte
9 39,1%
Compra
5 21,7%
Mantener
0 0,0%
Venta
0 0,0%
Venta fuerte
Precio objetivo a 12 meses
16 analistas · 2026-09-28Objetivo medio $48.88 +45,4%
Ahora
Precio Actual $33.62
Mín$30.00
Media$48.88
Máx$66.00
Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector
Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.
| Ticker | Capitalización Bursátil | P/E | Ingresos interanuales | Margen Neto | ROE | Margen Bruto |
|---|---|---|---|---|---|---|
| IMVT | $5.07B | -9.0 | 229.2% | · | -73.7% | · |
| SYRE | $2.56B | 10.1 | -62.0% | · | -26.5% | · |
| CAI | $7.62B | -8.4 | 97.0% | -8.4% | -13.2% | · |
| IONS | $12.92B | -33.2 | · | · | -68.1% | · |
| RYTM | $7.19B | -34.4 | 45.8% | -103.6% | -309.1% | · |
| IOVA | $1.12B | -2.5 | 60.6% | -148.4% | -56.0% | · |
| GRAL | $3.45B | -7.7 | 17.2% | -277.5% | -16.7% | · |
| CGON | $3.35B | -20.0 | 254.7% | -3985.0% | -22.6% | · |
| SRRK | $4.78B | -13.4 | · | · | -157.9% | · |
Últimas noticias Noticias recientes que mencionan a esta empresa
Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos
Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.
Tu selección se guarda y te sigue en todos los tickers.
Fuente: SEC 10-Q presentada el Ago 6, 2026